Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Healthcare And Mid-Cap: 2 ETFs To Watch On Outsized Volume

Published 05/08/2019, 08:24 AM
Updated 07/09/2023, 06:31 AM
SPY
-
PTH
-

In the last trading session, U.S. stocks have been on a rocky ride given the new tariff threat that has escalated the trade spat between the United States and China. Among the top ETFs, investors saw SPY (NYSE:SPY) shed 1.6%, DIA lose 1.7%, and QQQ move 2% lower on the day.

Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues.

(HN:PTH) : Volume 9.65 Times Average

This healthcare ETF was under the microscope as 175,000 shares moved hands. This compares with average trading volume of roughly 18,000 shares and came as PTH lost 2% in the trading session.

The big move was largely the result of volatility, leading to investors’ defensive tilt that can have a big impact on healthcare stocks like what we find in this ETF portfolio. PTH has lost 1.4% over the past month and carries a Zacks ETF Rank #3 (Hold) with a High risk outlook.

IVOG: Volume 5.10 Times Average

This mid-cap ETF was in the spotlight as around 48,000 shares moved hands compared with an average 10,000 shares a day. We also saw some price movement as IVOG lost 2% in the last session.

The movement can largely be blamed on investors’ caution that compelled them to look for both growth and stability in their portfolio simultaneously. IVOG has shed 0.2% in a month’s time and has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Invesco DWA Healthcare Momentum ETF (PTH): ETF Research Reports

Vanguard S&P Mid-Cap 400 Growth ETF (IVOG): ETF Research Reports

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.